Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Intellia Therapeutics, Inc.

NASDAQ: NTLA · Life Sciences · 6 alerts · CIK 1652130

Share price
$9.86Close, Nov 16
Market cap
$1.38B
Shares outstanding
140.36MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Intellia Therapeutics, Inc. filings on SEC EDGAR ↗

5:06 PM ET 8-K/A
Investor Presentation

Intellia Therapeutics Investor Presentation

Intellia Therapeutics hosted a webcast and filed a formal investor presentation titled 'Readying Lonvo-z for Patients with HAE.' The presentation focused on the commercial potential and clinical data for lonvoguran ziclumeran (lonvo-z), a CRISPR-based therapy for hereditary angioedema.

4:15 PM ET 8-K
Investor Presentation

Intellia Therapeutics Investor Presentation

Intellia Therapeutics hosted a webcast for investors and analysts titled 'Readying Lonvo-z for Patients with HAE' to discuss the development and commercialization strategy for its CRISPR-based therapy, lonvoguran ziclumeran. The presentation focused on the clinical data and market potential for lonvo-z in treating hereditary angioedema (HAE).

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.